UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| 1 |
Pinduoduo
PDD
|
+$1.65B |
| 2 |
Accenture
ACN
|
+$1.54B |
| 3 |
Linde
LIN
|
+$1.24B |
| 4 |
Prologis
PLD
|
+$1.08B |
| 5 |
Microsoft
MSFT
|
+$914M |
Top Sells
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$809M |
| 2 |
Blackrock
BLK
|
+$809M |
| 3 |
Lam Research
LRCX
|
+$735M |
| 4 |
Meta Platforms (Facebook)
META
|
+$563M |
| 5 |
UBS Group
UBS
|
+$411M |
Sector Composition
| 1 | Technology | 33.21% |
| 2 | Financials | 12.03% |
| 3 | Healthcare | 11.96% |
| 4 | Consumer Discretionary | 10.89% |
| 5 | Communication Services | 8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
LBPH
2051
DELISTED
Longboard Pharmaceuticals, Inc. Common Stock
LBPH
| $1.84M | ﹤0.01% |
55,079
+5,023
| +10% | +$167K |
|
2052
SoundHound AI
SOUN
$5.73B
| $1.84M | ﹤0.01% |
393,858
-39,989
| -9% | -$186K |
|
2053
Barrett Business Services
BBSI
$1.18B
| $1.83M | ﹤0.01% |
48,827
-9,153
| -16% | -$343K |
|
2054
Genco Shipping & Trading
GNK
$772M
| $1.83M | ﹤0.01% |
93,903
-2,643
| -3% | -$51.5K |
|
2055
AdaptHealth
AHCO
$1.24B
| $1.82M | ﹤0.01% |
162,470
+11,757
| +8% | +$132K |
|
2056
Wabash National
WNC
$461M
| $1.82M | ﹤0.01% |
95,032
-2,346
| -2% | -$45K |
|
2057
iShares Broad USD High Yield Corporate Bond ETF
USHY
$25.1B
| $1.82M | ﹤0.01% |
+48,333
| New | +$1.82M |
|
2058
Amneal Pharmaceuticals
AMRX
$3.08B
| $1.82M | ﹤0.01% |
218,554
-46,170
| -17% | -$384K |
|
2059
BrightView Holdings
BV
$1.31B
| $1.82M | ﹤0.01% |
115,435
-7,731
| -6% | -$122K |
|
2060
Blue Bird Corp
BLBD
$1.82B
| $1.81M | ﹤0.01% |
37,746
-4,069
| -10% | -$195K |
|
2061
MoonLake Immunotherapeutics
MLTX
$3.44B
| $1.81M | ﹤0.01% |
35,814
+17,580
| +96% | +$886K |
|
|
KREF
2062
KKR Real Estate Finance Trust
KREF
$644M
| $1.8M | ﹤0.01% |
145,896
+86,327
| +145% | +$1.07M |
|
2063
Shutterstock
SSTK
$715M
| $1.79M | ﹤0.01% |
50,746
-11,627
| -19% | -$411K |
|
2064
Equinox Gold
EQX
$8.4B
| $1.79M | ﹤0.01% |
294,574
-45,791
| -13% | -$279K |
|
2065
Cassava Sciences
SAVA
$101M
| $1.79M | ﹤0.01% |
60,894
-13,075
| -18% | -$385K |
|
2066
Establishment Labs
ESTA
$1.1B
| $1.79M | ﹤0.01% |
41,351
+19,531
| +90% | +$845K |
|
2067
Sphere Entertainment
SPHR
$1.97B
| $1.79M | ﹤0.01% |
40,481
-4,054
| -9% | -$179K |
|
2068
Enviri
NVRI
$959M
| $1.79M | ﹤0.01% |
172,781
-24,280
| -12% | -$251K |
|
2069
AMERISAFE
AMSF
$857M
| $1.78M | ﹤0.01% |
36,924
-9,022
| -20% | -$436K |
|
2070
Preferred Bank
PFBC
$1.17B
| $1.78M | ﹤0.01% |
22,161
-1,117
| -5% | -$89.6K |
|
2071
QuinStreet
QNST
$912M
| $1.78M | ﹤0.01% |
92,821
-16,685
| -15% | -$319K |
|
2072
Phathom Pharmaceuticals
PHAT
$874M
| $1.77M | ﹤0.01% |
98,025
+4,871
| +5% | +$88.1K |
|
2073
TORM
TRMD
$2.21B
| $1.77M | ﹤0.01% |
51,782
-1,439
| -3% | -$49.2K |
|
|
ETWO
2074
DELISTED
E2open Parent Holdings
ETWO
| $1.77M | ﹤0.01% |
400,979
-44,527
| -10% | -$196K |
|
2075
Kimball Electronics
KE
$735M
| $1.77M | ﹤0.01% |
95,526
+556
| +0.6% | +$10.3K |
|